Exelixis Share Price

Exelixis Share Price

NASDAQ: EXEL | Large Cap | Healthcare
$64.66
-$1.09 (-1.67%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Exelixis Stock Performance

Open
$66.16
Prev. Close
$65.75
Circuit Range
N/A
Day Range
$64.45 - $66.85
Year Range
$39.72 - $73.55
Volume
1,09,515
Average Traded
$65.30

Exelixis Share Price Today

As of 21 November 2026, Exelixis, Inc.'s share price is $64.66. The stock opened at $66.16, compared to its previous close of $65.75. During today's trading session, Exelixis, Inc.'s share price traded between $64.45 and $66.85, with an average price of $65.65. Over the past 52 weeks, the stock has recorded a high of $73.55 and a low of $39.72. In terms of performance, Exelixis, Inc.'s share price has risen by 28.06% over the last six months and is up 46.39% on a year-on-year basis.

Exelixis Share Price Chart

Line chart of the Exelixis price trend over the selected period. The price fell overall, ranging from 64.48 to 66.85, ending at 64.66.
$64.45$66.85
L
Show Current Price
H

Exelixis Stock Fundamentals & Key Indicators

Market Cap
$17.56B
PE Ratio (TTM)
17.82
Dividend Yield
0.00%
EPS (TTM)
$3.63
Revenue (TTM)
$2.32T
Return On Equity (TTM)
48.27%
Profit Margin
33.73%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-10.81%

Exelixis Quarterly Profit & Loss

All figures in USD

ParticularsJan 2026Apr 2026Jul 2026Oct 2026
Revenue$598.66$610.81$628.69$658.70
Net Profit$244.53$210.47$212.05$218.10
Net Profit Margin40.85%34.46%33.73%33.11%
Income ChangeN/A-13.93%0.75%2.85%

Exelixis Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1611.06$1830.21$2168.70$2320.13
Net Profit$182.28$207.77$521.27$782.57
Net Profit Margin11.31%11.35%24.04%33.73%
Income ChangeN/A13.98%150.89%50.13%

Exelixis Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets1401.131480.111624.41452.73
Current Assets1443.291467.581317.961618.76
Total Assets2844.422947.692942.363071.49
Non Current Liabilities277.46299.72284.17258.7
Current Liabilities405.64403.77394.28324.36
Total Liabilities683.1703.49678.45583.06
Shareholders' Equity2161.322244.22263.912488.43

Exelixis Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating884.27699.97333.32362.61
Investing350.44-116.78-26.96-524.41
Financing-969.59-628.81-546.050.59

About Exelixis

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Exelixis Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$69.22
$64.58
-6.92%
Oct 2026
$58.29
$69.38
+18.72%
Sep 2026
$55.09
$58.44
+5.76%
Aug 2026
$52.81
$55.26
+4.17%
Jul 2026
$54.34
$53.05
-2.48%
Jun 2026
$50.68
$54.40
+7.73%
May 2026
$44.06
$50.49
+13.54%
Apr 2026
$42.91
$44.47
+3.68%
Mar 2026
$41.95
$42.89
-2.62%
Feb 2026
$41.85
$44.05
+6.52%
Jan 2026
$43.52
$41.35
-5.62%
Dec 2025
$43.62
$43.81
-0.80%

Exelixis Share Price FAQs